Effect of Alpha Lipoic Acid on Prevention of Diabetic Peripheral Neuropathy
Not Applicable
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2023/07/054908
- Lead Sponsor
- Tanuja P Pattankar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Known type 2 diabetics diagnosed at least one year prior to the commencement of study.
Exclusion Criteria
Patients with type 1 DM, Gestational DM and critically ill patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in the score of Total Symptom Score (TSS)Timepoint: At Baseline and end of 6 weeks
- Secondary Outcome Measures
Name Time Method To assess the reduction in total symptom score of Diabetic peripheral neuropathy after the intervention with alpha lipoic acid which is an anti - oxidant seems to delay or reverse peripheral diabetic neuropathy at the begining of the study, after 5 weeks and after 3 months.Timepoint: baseline data, after 5 weeks, after 3 months.